Australian Clinical Labs Ltd (AU:ACL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Australian Clinical Labs Ltd has announced an update on its ongoing share buy-back program, revealing that it repurchased 125,000 shares on the previous day. This move brings the total number of shares bought back to 955,864, highlighting the company’s strategy to potentially enhance shareholder value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.